Human umbilical cord wharton's jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Umbilical cord mesenchymal stem cells (MSCs) have been shown to inhibit breast cancer cell growth but it is not known whether this effect is specific to only breast cancer cells. We compared the effects of human Wharton's jelly stem cell (hWJSC) extracts [conditioned medium (hWJSC‐CM) and cell lysate (hWJSC‐CL)] on breast adenocarcinoma (MDA‐MB‐231), ovarian carcinoma (TOV‐112D), and osteosarcoma (MG‐63) cells. The cells were treated with either hWJSC‐CM (50%) or hWJSC‐CL (15 µg/ml) for 48–72 h and changes in cell morphology, proliferation, cycle, gene expression, migration, and cell death studied. All three cancer cell lines showed cell shrinkage, blebbing, and vacuolations with hWJSC‐CL and hWJSC‐CM compared to controls. MTT and BrdU assays showed inhibition of cell growth by 2–6% and 30–60%, while Transwell migration assay showed inhibition by 20–26% and 31–46% for hWJSC‐CM and hWJSC‐CL, respectively, for all three cancer cell lines. Cell cycle assays showed increases in sub‐G1 and G2/M phases for all three cancer cell lines suggestive of apoptosis and metaphase arrest. AnnexinV‐FITC and TUNEL positive cells seen in TOV‐112D and MDA‐MB‐231 suggested that inhibition was via apoptosis while the presence of anti‐BECLIN1 and anti‐LC3B antibodies seen with MG‐63 indicated autophagy. Upregulation of pro‐apoptotic BAX and downregulation of anti‐apoptotic BCL2 and SURVIVIN genes were observed in all three cancer cell lines and additionally the autophagy genes (ATG5, ATG7, and BECLIN1) were upregulated in MG‐63 cells. hWJSCs possess tumor inhibitory properties that are not specific to breast cancer cells alone and these effects are mediated via agents in its extracts. J. Cell. Biochem. 113: 2027–2039, 2012. © 2012 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Khakoo, A. Y., Pati, S., Anderson, S. A., Reid, W., Elshal, M. F., Rovira, I. I., Nguyen, A. T., Malide, D., Combs, C. A., Hall, G., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051921 · Cited by 747
Human Umbilical Cord Mesenchymal Stem Cells Reduce Fibrosis of Bleomycin-Induced Lung Injury
Moodley, Y., Atienza, D., Manuelpillai, U., Samuel, C. S., Tchongue, J., Ilancheran, S., Boyd, R., & Trounson, A. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080629 · Cited by 356
Seo, S. H., Kim, K. S., Park, S. H., Suh, Y. S., Kim, S. J., Jeun, S.-S., & Sung, Y. C. (2011) · Gene Therapy · doi:10.1038/gt.2010.170 · Cited by 148 · cited 1×
“MSCs engineered to express modified IL-12 were shown to induce T-cell responses and anti-tumor effects in melanomas in mice [Seo et al., 2011].”
BackgroundMesenchymal stem cells: an emerging tool for cancer targeting and therapy
Fritz, V., & Jorgensen, C. (2008) · Current Stem Cell Research & Therapy · doi:10.2174/157488808783489462 · Cited by 79
Cited by
Human Umbilical Cord Mesenchymal Stem Cells: A New Era for Stem Cell Therapy
Ding, D.-C., Chang, Y.-H., Shyu, W.-C., & Lin, S.-Z. (2015) · Cell Transplantation · doi:10.3727/096368915x686841 · Cited by 613
L., P. K., Kandoi, S., Misra, R., S., V., K., R., & Verma, R. S. (2019) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2019.04.002 · Cited by 484
El Omar, R., Beroud, J., Stoltz, J.-F., Menu, P., Velot, E., & Decot, V. (2014) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2013.0664 · Cited by 330
Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy
Li, T., Xia, M., Gao, Y., Chen, Y., & Xu, Y. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1051528 · Cited by 263
Zhuang, W.-Z., Lin, Y.-H., Su, L.-J., Wu, M.-S., Jeng, H.-Y., Chang, H.-C., Huang, Y.-H., & Ling, T.-Y. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00725-7 · Cited by 258
Mesenchymal stem cell secretome for regenerative medicine: Where do we stand?
Trigo, C. M., Rodrigues, J. S., Camões, S. P., Solá, S., & Miranda, J. P. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2024.05.004 · Cited by 252
Wu, S., Ju, G.-Q., Du, T., Zhu, Y.-J., & Liu, G.-H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061366 · Cited by 224
“Emerging evidence suggests that MSCs show antitumor effect upon multiple tumor cells, such as Kaposi’ sarcoma [1], glioma cells [37], breast cancer [3,4,38] and Non-Hodgkin’s Lymphoma [2].”
BackgroundResultZheng, Y., Wang, G., Chen, R., Hua, Y., & Cai, Z. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0780-x · Cited by 127
“When OS cells (MG-63) were cultured in human WJ-MSC-conditioned medium, their growth, including proliferation and migration in vitro, was inhibited [41].”
BackgroundMesenchymal stem cells in preclinical cancer cytotherapy: a systematic review
Christodoulou, I., Goulielmaki, M., Devetzi, M., Panagiotidis, M., Koliakos, G., & Zoumpourlis, V. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1078-8 · Cited by 122
Role of MSC in the Tumor Microenvironment
Hass, R. (2020) · Cancers · doi:10.3390/cancers12082107 · Cited by 116
“These include distinct repair activity for damaged tissues [6], involvement in regenerative processes [7], immune-modulatory potential [8], neovascularization [9], paracrine activities, antimicrobial functions [10], and tumor-inhibitory [11] and tumor-promoting properties [12–14].”
BackgroundMesenchymal Stem Cells and Extracellular Vesicles in Osteosarcoma Pathogenesis and Therapy
Sarhadi, V. K., Daddali, R., & Seppänen-Kaijansinkko, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011035 · Cited by 63
“In another study, Wharton’s jelly-derived MSCs (WJ-MSCs), when cultured with OS cells in a WJ-MSC-conditioned medium, resulted in the inhibition of OS cell proliferation and migration, with the upregulation of pro-apoptotic BAX and downregulation of antiapoptotic BCL2 and SURVIVIN, as well as the upregulation of autop…”
Influence of mesenchymal stem cells on metastasis development in mice in vivo
Meleshina, A. V., Cherkasova, E. I., Shirmanova, M. V., Klementieva, N. V., Kiseleva, E. V., Snopova, L. В., Prodanets, N. N., & Zagaynova, E. V. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0003-7 · Cited by 45
“The conditioned media of MSCs isolated from human umbilical cord or Wharton’s jelly inhibited proliferation of MDAMB-231 and other tumor cell lines by arresting the cell cycle in the G2/M phase and induced apoptosis in vitro [44].”
Background
Metadata
- Authors
- Gauthaman, K., Yee, F. C., Cheyyatraivendran, S., Biswas, A., Choolani, M., & Bongso, A.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2012-04-10
- Volume
- 113
- Issue
- 6
- Pages
- 2027-2039
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W2041858615
- Cited by
- 152
- References
- 4
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.